Suppr超能文献

氨基酸及其衍生物对经典途径和替代途径的抑制作用。

Inhibition of the classical and alternative pathways by amino acids and their derivatives.

作者信息

Takada Y, Arimoto Y, Mineda H, Takada A

出版信息

Immunology. 1978 Mar;34(3):509-15.

Abstract

Effects of various aminoacids and their derivatives on the classical pathway and alternative pathway of the complement were studied. Leupeptin, acetyl-leucyl-leucyl-arginal, inhibited CH50 and Cl-esterase, but did not inhibit the alternative pathway. When aminoacids of carbon chains of the order of seven were used, arginine and lysine had stronger effects than trans-aminomethyl cyclohexane carboxylic acid (t-AMCHA), cis-aminomethyl cyclohexane carboxylic acid (cis-AMCHA) and epsilon aminocaproic acid (EACA). SH-compounds, cysteine, homocysteine and glutathione, had the strongest inhibitory effects among these aminoacids on both classical and alternative pathways. When effects on Cl esterase were compared, arginine, lysine, t-AMCHA, cis-AMCHA and EACA had weak inhibition while SH-compounds showed strong inhibition. Poly-L-lysine, which had extremely strong inhibition of CH50, had no inhibition of Cl esterase. The inhibitory effects of antifibrinolytic agents, EACA and t-AMCHA, were weak but when effects on early parts of the classical pathway, C(1,4,2)H50 were tested, some inhibitory activities were recognized. Thus inhibitory effects of these agents were due to their activities on the early parts of the classical pathway.

摘要

研究了各种氨基酸及其衍生物对补体经典途径和替代途径的影响。亮抑蛋白酶肽,即乙酰 - 亮氨酰 - 亮氨酰 - 精氨酸甲酯,抑制CH50和Cl酯酶,但不抑制替代途径。当使用碳链长度约为七个单位的氨基酸时,精氨酸和赖氨酸的作用比反式氨基甲基环己烷羧酸(t - AMCHA)、顺式氨基甲基环己烷羧酸(顺式 - AMCHA)和ε - 氨基己酸(EACA)更强。含硫化合物,如半胱氨酸、同型半胱氨酸和谷胱甘肽,在这些氨基酸中对经典途径和替代途径的抑制作用最强。当比较对Cl酯酶的作用时,精氨酸、赖氨酸、t - AMCHA、顺式 - AMCHA和EACA的抑制作用较弱,而含硫化合物表现出较强的抑制作用。对CH50有极强抑制作用的聚 - L - 赖氨酸对Cl酯酶没有抑制作用。抗纤维蛋白溶解剂EACA和t - AMCHA的抑制作用较弱,但当测试它们对经典途径早期部分C(1,4,2)H50的作用时,可观察到一些抑制活性。因此,这些药物的抑制作用是由于它们对经典途径早期部分的活性。

引用本文的文献

1
针对B因子的单克隆抗体可阻断全毒素激活补体。
Infect Immun. 1994 Oct;62(10):4549-55. doi: 10.1128/iai.62.10.4549-4555.1994.
4
新型替代补体途径合成抑制剂。
Immunology. 1983 Aug;49(4):685-91.
5
人类补体替代途径的C3转化酶。双分子蛋白酶的酶学特性。
Biochem J. 1986 May 1;235(3):723-30. doi: 10.1042/bj2350723.
8
抗纤溶药物控制的慢性胃肠道出血。
Postgrad Med J. 1989 Mar;65(761):185-7. doi: 10.1136/pgmj.65.761.185.
9
人卵巢卵泡液中的补体、补体激活及过敏毒素
Clin Exp Immunol. 1990 Nov;82(2):359-62. doi: 10.1111/j.1365-2249.1990.tb05453.x.
10
功能性活性补体存在于人类卵巢卵泡液中,且可被精浆激活。
Clin Exp Immunol. 1992 Jul;89(1):154-7. doi: 10.1111/j.1365-2249.1992.tb06895.x.

本文引用的文献

2
氨基酸对补体C'-1成分的抑制作用。
Immunology. 1964 Jul;7(4):319-31.
5
纤溶酶对合成底物作用速率的测定。
J Biol Chem. 1958 May;232(1):285-91.
7
纤溶酶对C1灭活剂的抑制作用。
J Clin Invest. 1970 Mar;49(3):568-75. doi: 10.1172/JCI106267.
8
补体C3的纤溶酶裂解片段作为一种新的趋化因子。
J Exp Med. 1967 Aug 1;126(2):189-206. doi: 10.1084/jem.126.2.189.
9
纤溶酶和胰蛋白酶将C'IS转化为C'1酯酶。
J Exp Med. 1967 Feb 1;125(2):337-58. doi: 10.1084/jem.125.2.337.
10
兔细胞对人补体替代途径的激活。
J Immunol. 1974 Jul;113(1):348-58.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验